PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 42 filers reported holding PROTARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $819,000 | – | 52,026 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $8,077,883 | 2.42% |
| Privium Fund Management (UK) Ltd | 119,730 | $401,096 | 0.32% |
| Ikarian Capital, LLC | 188,664 | $584,859 | 0.13% |
| Orbimed Advisors | 793,558 | $2,483,837 | 0.05% |
| Boxer Capital, LLC | 209,227 | $655 | 0.03% |
| Perceptive Advisors | 290,051 | $907,860 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $198,400 | 0.01% |
| Baker Brothers Advisors | 199,671 | $624,970 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $59,044 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 35,745 | $111,882 | 0.00% |